Clinical Trial: Activity of Mefloquine Against Urinary Schistosomiasis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Activity of Mefloquine Against Urinary Schistosomiasis

Brief Summary: Urinary schistosomiasis is a debilitating disease in Central Africa and pregnant women are frequently suffering from this condition. Mefloquine is currently investigated as preventive treatment against malaria in pregnancy and mefloquine is also known to exert activity against schistosomiasis. The investigators want to test the hypothesis whether mefloquine may active against urinary schistosomiasis when used as preventive treatment against malaria in pregnancy.